Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder

Journal of Psychosomatic Research

Volumn 55, Issue 6, 2003, Pages 507-513

  Yeragani, Vikram Kumar ^a   Rao, Radhakrishna ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Antidepressants; Cardiac; Chaos; Largest Lyapunov exponent; Nortriptyline; Paroxetine

Indexed keywords

ANTIDEPRESSANT AGENT; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENERGIC SYSTEM; ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; HEART DISEASE; HEART RATE; HUMAN; MALE; MEASUREMENT; MENTAL PATIENT; PANIC;

EID: 1042289482     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(03)00023-0     Document Type: Article

References (78)

1. Kawachi I., Colditz G.A., Ascherio A., Rimm E.B., Giovanucci E., Stampfer M.J., Willett W.C. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 89:1994;1992-1997.
2. Kawachi I., Sparrow D., Vokonas P.S., Weiss S.T. Symptoms of anxiety and risk of coronary heart disease: the normative aging study. Circulation. 90:1994;2225-2229.
3. Frasure-Smith N., Lesperance F., Taljic M. Depression and 18 month prognosis after myocardial infarction. Circulation. 91:1995;999-1005.
4. Carney R.M., Freedland K.E., Rich M.W., Smith L.J., Jaffe A.S. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med. 95:1993;23-28.
5. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry. 55:1998;580-592.
6. Kleiger R.E., Miller J.P., Bigger J.T., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 59:1987;256-262.
7. Bigger J.T., Fleiss J.L., Steinman R., Rolnitzky L.M., Kleiger R.E., Rottman J.N. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 85:1992;164-171.
8. Molgaard H., Sorensen K.E., Bjerregard P. Attenuated 24-hour heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1:1991;233-237.
9. Berger R.D., Casper E.K., Baughman K.L., Marban E., Calkins H., Tomaselli G.F. Beat-to-beat QT interval variability. Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation. 96:1996;1557-1565.
10. Atiga W.L., Calkins H., Lawrence J.H., Tomaselli G.F., Smith J.M., Berger R.D. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol. 9:1998;899-908.
11. Vrtovec B., Starc V., Starc R. Beat-to-beat QT interval variability in coronary patients. J Electrocardiol. 33:2000;119-125.
12. Atiga W.L., Fananpazir L., McAreavey D., Calkins H., Berger R.D. Temporal repolarization lability in hypertensive cardiomyopathy caused by beta-chain heavy gene mutations. Circulation. 101:2000;1237-1242.
13. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Barger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 213:1981;220-222.
14. Pomeranz B., Macaulay R.J.B., Caudill M.A., Kutz I., Adam D., Gordon D., Kilborn K.M., Barger A.C., Shannon D.C., Cohen R.J., Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 248:1985;H151-H153.
15. Lindqvist A., Jalonen J., Parviainen P., Antilla K., Laitinen L.A. Effect of posture on thermally stimulated cardiovascular oscillations. Cardiovasc Res. 24:1990;373-380.
16. Yeragani V.K., Roose S., Mallavarapu M., Radhakrishna R.K., Pesce V. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiology. 46:2002;125-135.
17. Roose S.P., Laghrissi-Thode F., Kennedy J.S., Nelson J.C., Bigger J.T., Pollock B.G., Gaffney A., Narayan M., Finkel M.S., McCafferty J., Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 279:1998;287-291.
18. Roose S.P., Glassman A.H., Atria E., Woodring S., Giardina E.G., Bigger J.T. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry. 155:1998;660-665.
19. Yeragani V.K., Srinivasan K., Pohl R., Berger R., Balon R., Ramesh C., Berchou R. Effects of nortriptyline on heart rate variability in panic disorder patients: a preliminary study using power spectral analysis of heart rate. Neuropsychobiology. 29:1994;1-7.
20. Yeragani V.K., Jampala V.C., Sobolewski E., Kay J., Igel G. Effects of paroxetine on heart period variability in patients with panic disorder: a study of Holter ECG records. Neuropsychobiology. 40:1999;124-128.
21. Pollock B.G., Mulsant B.H., Nebes R., Kirshner M.A., Begley A.E., Mazumdar S.A., Reynolds C.F. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. Am J Psychiatry. 158:1998;1110-1112.
22. Yeragani VK, Radhakrishna Rao KA, Tancer M, Uhde T Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic disorder: a preliminary report. Submitted for publication.
23. Yeragani V.K., Pohl R., Jampala V.C., Balon R., Ramesh C., Srinivasan K. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety. 11:2000;126-130.
24. Roose S.P., Spatz E. Treating depression in patients with ischemic heart disease: which agents are best to use and avoid? Drug Saf. 20:1999;459-465.
25. Rechlin T., Claus D., Weis M. Heart rate analysis in 24 patients treated with 150 mg amitriptyline per day. Psychopharmacology (Berlin). 116:1994;110-114.
26. Khaykin Y., Dorian P., Baker B., Shapiro C., Sandor P., Mironov D., Irvine J., Newman D. Autonomic correlates of antidepressant treatment using heart rate variability analysis. Can J Psychiatry. 43:1998;183-186.
27. Tucker P., Adamson P., Miranda R., Scarborough A., Williams D., Goff J., McClean H. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol. 17:1997;370-376.
28. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffman P., Jaffe A.S. Change in heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med. 62:2000;639-647.
29. Radhakrishna R.K.A., Narayana Dutt D., Yeragani V.K. Nonlinear measures of heart rate time series. Influence of posture and controlled breathing. Auton Neurosci. 83:2000;148-158.
30. Radhakrishna R.K.A., Yeragani V.K. Decreased chaos and increased nonlinearity of heart rate time series in patients with panic disorder. Auton Neurosci. 88:2001;99-108.
31. Yeragani V.K., Radhakrishna R.K.A., Pohl R., Balon R., Srinivasan K. Decreased Degree of chaos of heart rate time series in patients with, major depression. Biol Psychiatry. 51:2002;733-744.
32. Hagerman I., Berglund M., Lorin M., Nowak J., Sylven C. Chaos deterministic regulation of heart rate variability in time and frequency domains: effects of autonomic blockade and exercise. Cardiovasc Res. 31:1996;410-418.
33. Zweiner U., Hoyer D., Bauer R., Luthke B., Walter W., Schmidt K., Hallmeyer S., Kratzsch B., Eiselt M. Deterministic chaotic and periodic properties of heart rate and arterial fluctuations and their mediation in piglets. Cardiovasc Res. 31:1996;455-465.
34. Yeragani V.K., Nadella R., Hinze B., Yeragani S., Jampala V.C. Nonlinear measures of heart period variability: decreased measures of symbolic dynamics in patients with panic disorder. Depress Anxiety. 12:2000;67-77.
35. Yeragani VK, Radhakrishna RKA, Smitha MR, Ramakrishnan KR, Srinivasan HS. Relationship of measures of nonlinearity and LLE of unfiltered time series of heart rate to those in different frequency bands; A possible measure of vagal and relative sympathetic activity. Submitted for publication.
36. Yeragani V.K., Pohl R., Balon R., Berchou R., Srinivasan K., Glitz D. Effect of intravenous sodium lactate and isoproterenol infusions in normal controls and patients with panic disorder on nonlinear indices of heart rate variability. Psychiatry Res. 101:2002;81-92.
37. Cacioppo J.T., Berntson G.G., Ginkley P.F., Quigley K.S., Uchino B.N., Fieldstone A. Autonomic cardiac control: II. Noninvasive indices and basal response as revealed by autonomic blockades. Psychophysiology. 31:1994;586-598.
38. Pagani M., Lombardi F., Guzzetti S., Rimoldi O., Furlan R., Pizzinelli P., Sandrone G., Malfatto G., Dell'Orto S., Piccaluga E., Turiel M., Basellli G., Cerutti S., Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res. 59:1986;178-193.
39. Yeragani V.K., Pohl R., Berger R., Balon R., Ramesh C., Glitz D., Srinivasan K., Weinberg P. Decreased heart rate variability in panic disorder patients. A study of power spectral analysis of heart rate. Psychiatry Res. 46:1993;89-103.
40. Yeragani V.K., Sobolewski E., Igel G., Johnson C., Jampala V.C., Kay J., Hillman N., Yeragani S., Vempati S. Decreased heart period variability in patients with panic disorder: a study of Holter ECG records. Psychiatry Res. 78:1998;89-99.
41. Spitzer R.L., Williams J.B.W., Gibbon M. Structured Clinical Interview for DSM III-R (SCID). 1987;Biometrics Research, New York State Psychiatric Institute, New York.
42. Spielberger C.D., Gorusch R.L., Luschene R.E. State-Trait Anxiety Inventory. 1970;Consulting Psychologists Press, Palo Alto, CA.
43. Berger R.D., Akselrod S., Gordon D., Cohen R.J. An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng. 33:1986;900-904.
44. Takens F. Detecting strange attractors in turbulence. Rand D., Young L. Dynamical Systems and Turbulence. Lecture Notes on Mathematics. vol. 898:1980;366-381 Springer-Verlag, Berlin.
45. Grassberger P., Procaccia I. Measuring the strangeness of strange attractors. Physica D. 9:1983;189-208.
46. Theiler J. Efficient algorithm for estimating the correlation dimension from a set of discrete points. Phys Rev A. 36:1987;4456-4462.
47. Broomhead D.S., King G.P. Extracting qualitative dynamics from experimental data. Physica D. 20:1986;217-236.
48. Mees A.I., Rapp P.E., Jennings L.S. Singular value decomposition and embedding dimension. Phys Rev A. 37:1987;340-346.
49. Kennel M.B., Brown R., Abarbanel H.D. Determining minimum embedding dimension using a geometrical construction. Phys Rev A. 45:1992;3403-3411.
50. Cao L. Practical method for determining the minimum embedding dimension of a scalar time series. Physica D. 110:1997;43-50.
51. Sano M., Sawada Y. Measurement of the Lyapunov spectrum from a chaotic time series. Phys Rev Lett. 55:1985;1082-1085.
52. Wolf A., Swift J., Swinney H., Vastano J. Determining Lyapunov exponents from a time series. Physica D. 16:1985;285-317.
53. Sato S., Sano M., Sawada Y. Practical methods of measuring the generalized dimension and largest Lyapunov exponents in high-dimensional chaotic systems. Prog Theor Phys. 77:1987;1-5.
54. Zeng X., Eykholt R., Pielke R.A. Estimating the Lyapunov-exponent spectrum from short time series of low precision. Phys Rev Lett. 66:1991;3229-3232.
55. Rosenstien M., Collins J.J., De C., Luca J. A practical method for calculating largest Lyapunov exponents from small data sets. Physica D. 65:1993;117-134.
56. Yeragani V.K., Srinivasan K., Vempati S., Pohl R., Balon R. Fractal dimension of heart rate time series: an effective measure of autonomic function. J Appl Physiol. 75:1993;2429-2438.
57. Yeragani V.K., Sobolewski E., Kay J., Jampala V.C., Igel G. Effect of age on long-term heart rate variability. Cardiovasc Res. 35:1997;35-42.
58. Rozanski A., Bairey C.N., Krantz D.S., Friedman J., Resse K.J., Morrell M., Hilton-Shalfen S., Hestrin L., Bietendorf J., Berman D.S. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med. 318:1988;1005-1012.
59. Tomaselli G.F., Buckelman D.J., Calkins H.G. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 90:1994;2534-2539.
60. Binah O., Rosen M. Mechanisms of ventricular arrhythmias. Circulation. 85(Suppl. I):1992;I25-I31.
61. Schwartz P.J., Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation. 57:1978;1074-1077.
62. Schwartz P., Billman G.E., Stone H.L. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental model for sudden cardiac death. Circulation. 69:1984;790-800.
63. Yeragani V.K., Pesce V., Jayaraman A., Roose S. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychiatry. 52:2002;418-429.
64. Poon C.S., Merrill C.K. Decrease of cardiac chaos in congestive heart failure. Nature. 389:1997;492-495.
65. Voss A., Hnatkova K., Wessel N., Kurths J., Sander A., Schirdewan A., Camm A.J., Malik M. Multiparametirc analysis of heart rate variability used for risk stratification among survivors of acute myocardial infarction. Pacing Clin Electrophysiol. 21:1998;186-192.
66. Makikallio T.H., Hoiber S., Kober L., Torp-Pedersen C., Peng C.K., Goldberger A.L., Huikuri H.V. Fractal analysis of heart rate dynamics as a predictor of mortality in patients with depressed left ventricular function after acute myocardial infarction. TRACE investigators. Trandolapril cardiac evaluation. Am J Cardiol. 83:1999;836-839.
67. Huikuri H.V., Makakallio T., Airaksinen K.E., Mitrani R., Castellanos A., Myerburg R.J. Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol. 34:1999;1878-1883.
68. Huikuri H.V., Makikallio T.H. Heart rate variability in ischemic heart disease. Auton Neurosci. 20:2001;95-101.
69. Yeragani V.K., Rao K.A.R., Pohl R., Jampala V.C., Balon R. Heart rate and QT variability in children with anxiety disorders. Depress Anxiety. 13:2001;71-77.
70. Faustmann P.M., Ganz R.E. Central cardioautonomic disorganization in interictal states of epilepsy detected by phase space analysis. Int J Neurosci. 78:1994;43-47.
71. Ganz R.E., Weibels G., Stacker K.H., Faustmann P.M., Zimmermann C.W. The Lyapunov exponents of heart rate dynamics as a sensitive marker of central autonomic organization: an exemplary study of early multiple sclerosis. Int J Neurosci. 71:1993;29-36.
72. Monge-Argiles J.A., Palacios-Ortego F., Vila-Sobrino J.A., Matais-Guiu J. Heart rate variability in multiple sclerosis during a stable phase. Acta Neurol Scand. 97:1998;86-92.
73. Monge-Argiles J.A., Palacios Ortega F., Vila Sobrino J.A., Bautista Prados J., Perez Vicente J.A., Morales Ortiz A., Palao Sanchez A. Brain stem lesions decrease heart rate variability. Neurologia. 15:2000;158-163.
74. Nordenbo A.M., Boesen F., Andersen E.B. Cardiovascular autonomic function in multiple sclerosis. J Auton Nerv Syst. 26:1989;77-84.
75. Pool R. Is it healthy to be chaotic? Science. 243:1989;604-607.
76. Kawachi I., Sparrow D., Vokonas P.S., Weiss S.T. Decreased heart rate variability in men with phobic anxiety (data from the normative aging study). Am J Cardiol. 75:1995;882-885.
77. Carney R.M., Sounders R.D., Freedland K.E., Stein P., Rich M.W., Jaffe A.S. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 76:1995;562-564.
78. Yeragani V.K., Pohl R., Jampala V.C., Balon R., Ramesh C., Srinivasan K. Increased QT variability in patients with panic disorder and depression. Psychiatry Res. 93:2000;225-235.